|
RAB28 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62503344114384E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.21014309684142E-14 |
| Normal-vs-Stage2 |
1.13270000001719E-06 |
| Normal-vs-Stage3 |
4.12858636167357E-12 |
| Normal-vs-Stage4 |
1.64079860809352E-12 |
| Stage1-vs-Stage2 |
3.316200E-01 |
| Stage1-vs-Stage3 |
3.890400E-01 |
| Stage1-vs-Stage4 |
2.894100E-02 |
| Stage2-vs-Stage3 |
1.822580E-01 |
| Stage2-vs-Stage4 |
1.878400E-02 |
| Stage3-vs-Stage4 |
1.596410E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
5.404600E-04 |
| Normal-vs-Asian |
6.28110008449312E-10 |
| Caucasian-vs-AfricanAmerican |
3.342200E-02 |
| Caucasian-vs-Asian |
5.929400E-01 |
| AfricanAmerican-vs-Asian |
1.253030E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.32747196252603E-15 |
| Normal-vs-Female |
1.65512048511118E-12 |
| Male-vs-Female |
3.336200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63424829224823E-12 |
| Normal-vs-Age(41-60Yrs) |
2.0575763315378E-12 |
| Normal-vs-Age(61-80Yrs) |
1.91147098149713E-12 |
| Normal-vs-Age(81-100Yrs) |
3.848500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.069000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.774800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.177790E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.373200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.869390E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.074600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.818500E-03 |
| Classical-VS-Follicular |
9.501700E-02 |
| Classical-VS-Other |
4.105200E-01 |
| Classical-VS-Normal |
1.62558855265615E-12 |
| Tall-VS-Follicular |
3.795800E-04 |
| Tall-VS-Other |
5.916400E-01 |
| Tall-VS-Normal |
2.66464628140284E-12 |
| Follicular-VS-Other |
2.564200E-01 |
| Follicular-VS-Normal |
9.77180000028E-07 |
| Other-VS-Normal |
1.420870E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.18427490036765E-12 |
| Normal-vs-N1 |
1.46438416948058E-13 |
| N0-vs-N1 |
2.041600E-02 |
|
|
